76 related articles for article (PubMed ID: 7060045)
1. Cerebrospinal fluid versus serum concentrations of 5-FU, allopurinol, and oxypurinol during treatment of metastatic brain cancer with 5-FU infusion, allopurinol, and radiation.
Hornbeck CL; Floyd RA; Byfield JE; Griffiths JC; Frankel S; Sharp TR
Cancer Treat Rep; 1982 Mar; 66(3):571-3. PubMed ID: 7060045
[No Abstract] [Full Text] [Related]
2. [Excretion and serum concentrations of allopurinol, oxipurinol and oxipurines in combined treatment with allopurinol and benzbromarone in increasing doses].
Mertz DP; Borner K
Med Welt; 1983 Sep; 34(36):974-9. PubMed ID: 6633222
[No Abstract] [Full Text] [Related]
3. The effect of dietary protein on the clearance of allopurinol and oxypurinol.
Berlinger WG; Park GD; Spector R
N Engl J Med; 1985 Sep; 313(13):771-6. PubMed ID: 4033706
[TBL] [Abstract][Full Text] [Related]
4. [The clinical pharmacokinetics of allopurinol. 1. Allopurinol absorption sites and dose proportionality of allopurinol/oxipurinol bioavailability].
Schuster O; Haertel M; Hugemann B; Gikalov I; Schiemann O; Fenner H
Arzneimittelforschung; 1985; 35(4):760-5. PubMed ID: 4015743
[TBL] [Abstract][Full Text] [Related]
5. [Clinical pharmacokinetics of allopurinol. 3. Allopurinol/oxipurinol pharmacokinetics following administration of a controlled release allopurinol preparation].
Gikalov I; Radivojevich F; Schiemann O; Fenner H
Arzneimittelforschung; 1986 Jun; 36(6):988-93. PubMed ID: 3741536
[TBL] [Abstract][Full Text] [Related]
6. Allopurinol and oxypurinol are hydroxyl radical scavengers.
Moorhouse PC; Grootveld M; Halliwell B; Quinlan JG; Gutteridge JM
FEBS Lett; 1987 Mar; 213(1):23-8. PubMed ID: 3030809
[TBL] [Abstract][Full Text] [Related]
7. Absorption and metabolism of allopurinol and oxypurinol by rat jejunum in vitro: effects on uric acid transport.
Shaw MI; Parsons DS
Clin Sci (Lond); 1984 Mar; 66(3):257-67. PubMed ID: 6692658
[TBL] [Abstract][Full Text] [Related]
8. [Influence of benzbromarone on the pharmacokinetics and pharmacodynamics of oxipurinol].
Rüffer C; Zorn G; Henkel E; Mitzkat HJ
Arzneimittelforschung; 1982; 32(9):1149-52. PubMed ID: 6890841
[TBL] [Abstract][Full Text] [Related]
9. The bioavailability of two commercial preparations of allopurinol tablets.
Marcus M; Tse FL; Kleinberg SI
Int J Clin Pharmacol Ther Toxicol; 1982 Jul; 20(7):302-5. PubMed ID: 7107081
[TBL] [Abstract][Full Text] [Related]
10. Modulation of 5-fluorouracil toxicity by allopurinol in man.
Howell SB; Wung WE; Taetle R; Hussain F; Romine JS
Cancer; 1981 Sep; 48(6):1281-9. PubMed ID: 7023652
[TBL] [Abstract][Full Text] [Related]
11. High-dose allopurinol modulation of 5-FU toxicity: phase I trial of an outpatient dose schedule.
Campbell TN; Howell SB; Pfeifle C; House BA
Cancer Treat Rep; 1982 Sep; 66(9):1723-7. PubMed ID: 7116349
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of pyrazolo(3,4-d)pyrimidines in Leishmania braziliensis and Leishmania donovani. Allopurinol, oxipurinol, and 4-aminopyrazolo(3,4-d)pyrimidine.
Nelson DJ; Bugge CJ; Elion GB; Berens RL; Marr JJ
J Biol Chem; 1979 May; 254(10):3959-64. PubMed ID: 438170
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol.
Day RO; Graham GG; Hicks M; McLachlan AJ; Stocker SL; Williams KM
Clin Pharmacokinet; 2007; 46(8):623-44. PubMed ID: 17655371
[TBL] [Abstract][Full Text] [Related]
14. Elimination of allopurinol by the perfused rat liver preparation.
Pang KS
Res Commun Chem Pathol Pharmacol; 1979 Nov; 26(2):317-28. PubMed ID: 523774
[TBL] [Abstract][Full Text] [Related]
15. 5-FU and allopurinol: toxicity modulation and phase II results in colon cancer.
Kroener JF; Saleh F; Howell SB
Cancer Treat Rep; 1982 May; 66(5):1133-7. PubMed ID: 7083215
[TBL] [Abstract][Full Text] [Related]
16. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
Panomvana D; Sripradit S; Angthararak S
J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
[TBL] [Abstract][Full Text] [Related]
17. Difference of the plasma concentration and urinary excretion of allopurinol, oxypurinol, and purine bases between dietary intake and fasting.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Yamakita J; Higashino K
Int J Clin Pharmacol Ther; 1996 Apr; 34(4):157-62. PubMed ID: 8861734
[TBL] [Abstract][Full Text] [Related]
18. [Saliva and serum concentrations of oxipurinol after a single oral dose of allopurinol].
Mühlenbruch B; Arndt ML
Arch Pharm (Weinheim); 1982 Sep; 315(9):811-3. PubMed ID: 7138246
[No Abstract] [Full Text] [Related]
19. Biochemical modulation of intraperitoneal fluorouracil by allopurinol-the effect on an experimental adenocarcinoma in the liver.
Lindnér P; Carlsson G; Gustavsson B; Holmberg SB; Naredi P; Peterson A; Hafström L
Anticancer Res; 1994; 14(3A):847-52. PubMed ID: 8074485
[TBL] [Abstract][Full Text] [Related]
20. [A new and quick method for determination of allopurinol and oxipurinol in serum (author's transl)].
Nitsche V; Mascher H
Arzneimittelforschung; 1980; 30(11):1855-7. PubMed ID: 7192993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
